|By PR Newswire||
|January 9, 2013 07:15 AM EST||
NEW YORK, Jan. 9, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Urinary Tract Infections (UTI) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
GlobalData, the industry analysis specialist, has released its new report, "Urinary Tract Infections (UTI) Therapeutics - Pipeline Assessment and Market Forecasts to 2018". The report is an essential source of information and analysis on the global Urinary Tract Infections Therapeutics market. The report identifies the key trends shaping and driving the global Urinary Tract Infections Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Urinary Tract Infections Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
The report provides information on the key drivers and challenges of the Urinary Tract Infections Therapeutics market. Its scope includes -
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Urinary Tract Infections Therapeutics market revenues data from 2005 to 2010, forecast for eight years to 2018.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
- Analysis of the current and future competition in the seven key countries Urinary Tract Infections Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Urinary Tract Infections Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Urinary Tract Infections Therapeutics market
Reasons to buy
The report will enhance your decision making capability. It will allow you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Urinary Tract Infections Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Urinary Tract Infections Therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What's the next big thing in the global Urinary Tract Infections Therapeutics market landscape? – Identify, understand and capitalize.
1 Table of Contents1 Table of Contents 31.1 List of Tables 51.2 List of Figures 62 UTI Therapeutics - Introduction 72.1 Overview 72.2 Classification of UTI 72.2.1 Site of Infection 82.2.2 Based On Symptoms 82.2.3 Based on Recurrence 82.2.4 Based on Complicating Factors 82.2.5 Based on Origin of Infection 82.3 Epidemiology 92.4 Etiology 102.5 Risk Factors 102.6 Signs and Symptoms 112.7 Pathophysiology of UTI 112.8 Diagnosis and Treatment of UTI 122.9 GlobalData Pipeline Report Guidance 163 UTI Therapeutics - Market Characterization 173.1 UTI Therapeutics Market Size (2005-2010) - Global 173.2 UTI Therapeutics Market Forecast (2010-2018) - Global 193.3 UTI Therapeutics Market Size (2005-2010) - The US 213.4 UTI Therapeutics Market Forecast (2010-2018) - The US 223.5 UTI Therapeutics Market Size (2005-2010) - France 233.6 UTI Therapeutics Market Forecast (2010-2018) - France 243.7 UTI Therapeutics Market Size (2005-2010) - Germany 253.8 UTI Therapeutics Market Forecast (2010-2018) - Germany 263.9 UTI Therapeutics Market Size (2005-2010) - Italy 273.10 UTI Therapeutics Market Forecast (2010-2018) - Italy 283.11 UTI Therapeutics Market Size (2005-2010) - Spain 293.12 UTI Therapeutics Market Forecast (2010-2018) - Spain 303.13 UTI Therapeutics Market Size (2005-2010) - The UK 313.14 UTI Therapeutics Market Forecast (2010-2018) - The UK 323.15 UTI Therapeutics Market Size (2005-2010) - Japan 333.16 UTI Therapeutics Market Forecast (2010-2018) - Japan 343.17 Drivers and Barriers for the UTI Therapeutics Market 353.17.1 Drivers for the UTI Therapeutics Market 353.17.2 Barriers for the UTI Therapeutics Market 353.18 Key Events Impacting the Future Market 363.19 Opportunity and Unmet Need 363.20 Key Takeaway 374 UTI Therapeutics Market - Competitive Assessment 384.1 Overview 384.1.1 Strategic Competitor Assessment 384.2 Profiles of Commonly Used Products in the UTI Therapeutics Market 394.2.1 Ciprofloxacin 394.2.2 Doribax (doripenem) 404.2.3 Invanz (ertapenem sodium) 414.2.4 Levaquin (levofloxacin) 424.2.5 Fosfomycin tromethamine 424.2.6 Macrobid/Macrodantin (nitrofurantoin) 434.2.7 Bactrim/Septra (trimethoprim/sulfamethoxazole) 444.3 Key Takeaway 445 UTI Therapeutics Market - Pipeline Assessment 455.1 Overview 455.2 Strategic Pipeline Assessment 455.2.1 UTI Therapeutics - Phase III Pipeline 465.2.2 UTI Therapeutics - Phase II Pipeline 465.2.3 UTI Therapeutics – Phase I Pipeline 465.3 UTI Pipeline by Mechanism of Action 475.4 UTI Technology Trends Analytical Framework 485.5 UTI Therapeutics - Late-stage Drugs under Clinical Development 495.6 Molecule Profile for Late-stage Drugs under Clinical Development 505.6.1 CXA-201 (CXA-101/tazobactam) 505.6.2 CAZ-AVI (Avibactam/ceftazidime) 505.7 Key Takeaway 516 UTI Therapeutics - Clinical Trials Mapping 526.1 Clinical Trials by Country (US, EU5 and Japan) 526.2 Clinical Trials by Phase 536.3 Clinical Trials by Trial Status 546.4 Overall Sponsors 556.5 Prominent Sponsors 566.6 Top Companies Participating in UTI Therapeutics Clinical Trials 577 UTI Therapeutics - Strategic Assessment 587.1 UTI Therapeutics - Implications for Future Market Competition 588 UTI Therapeutics - Future Players 598.1 Introduction 598.1.1 AstraZeneca PLC 598.1.2 Cubist Pharmaceuticals 618.1.3 Forest Laboratories 639 UTI Therapeutics - Licensing and Partnership Deals 6510 UTI Therapeutics - Appendix 6710.1 Definitions 6710.2 Acronyms 6710.3 Research Methodology 6810.3.1 Coverage 6810.3.2 Secondary Research 6810.3.3 Forecasting 6910.3.4 Primary Research 7110.3.5 Expert Panel Validation 7110.4 Contact Us 7110.5 Disclaimer 7110.6 Bibliography 72
List of Tables
Table 1: UTI - Prevalence, Major Markets, 2010 9Table 2: UTI Therapeutics Market, Global, Revenue ($bn), 2005-2010 17Table 3: UTI Therapeutics Market, Global, Forecast ($bn), 2010-2018 19Table 4: UTI Therapeutics Market, The US, Revenue ($m), 2005-2010 21Table 5: UTI Therapeutics Market, The US, Forecast ($bn), 2010-2018 22Table 6: UTI Therapeutics Market, France, Revenue ($m), 2005-2010 23Table 7: UTI Therapeutics Market, France, Forecast ($m), 2010-2018 24Table 8: UTI Therapeutics Market, Germany, Revenue ($m), 2005-2010 25Table 9: UTI Therapeutics Market, Germany, Forecast ($m), 2010-2018 26Table 10: UTI Therapeutics Market, Italy, Revenue ($m), 2005-2010 27Table 11: UTI Therapeutics Market, Italy, Forecast ($m), 2010-2018 28Table 12: UTI Therapeutics Market, Spain, Revenue ($m), 2005-2010 29Table 13: UTI Therapeutics Market, Spain, Forecast ($m), 2010-2018 30Table 14: UTI Therapeutics Market, The UK, Revenue ($m), 2005-2010 31Table 15: UTI Therapeutics Market, The UK, Forecast ($m), 2010-2018 32Table 16: UTI Therapeutics Market, Japan, Revenue ($m), 2005-2010 33Table 17: UTI Therapeutics Market, Japan, Forecast ($m), 2010-2018 34Table 18: UTI Therapeutics - Phase III Pipeline 46Table 19: UTI Therapeutics - Phase II Pipeline 46Table 20: UTI Therapeutics – Phase I Pipeline 46Table 21: UTI Therapeutics - Late-stage Drugs Under Clinical Development, 2011 49Table 22: UTI Therapeutics - Clinical Trials by Country, 2011 52Table 23: UTI Therapeutics - Clinical Trials by Phase, 2011 53Table 24: UTI Therapeutics - Clinical Trials by Status, 2011 54Table 25: UTI Therapeutics, Overall Sponsors, 2011 55Table 26: UTI Therapeutics - Prominent Sponsors, 2011 56Table 27: UTI Therapeutics - Top Companies Participating in Clinical Trials, 2011 57Table 28: AstraZeneca Infectious Disease Pipeline, 2011 61Table 29: Cubist Pharmaceuticals Infectious Disease Pipeline, 2011 62Table 30: Forest Laboratories - Infectious Disease Pipeline, 2011 64Table 31: Licensing and Partnership Deals 65
List of Figures
Figure 1: Classification of UTI 7Figure 2: Principal Pathogens of UTI 10Figure 3: Symptoms of UTI 11Figure 4: Diagnostic Approach to UTI in Adults 12Figure 5: Different Class of Antibiotics Used for UTI 13Figure 6: Diagnosis and Treatment of UTI 14Figure 7: Diagnosis and Treatment of UTI 15Figure 8: UTI Therapeutics Market, Global, Revenue ($bn), 2005-2010 17Figure 9: UTI Therapeutics, Market Share ($m, %), 2010 18Figure 10: UTI Therapeutics Market, Global, Forecast ($bn), 2010-2018 19Figure 11: UTI Therapeutics, Market Share ($m, %), 2018 20Figure 12: UTI Therapeutics Market, The US, Revenue ($m), 2005-2010 21Figure 13: UTI Therapeutics Market, The US, Forecast ($bn), 2010-2018 22Figure 14: UTI Therapeutics Market, France, Revenue ($m), 2005-2010 23Figure 15: UTI Therapeutics Market, France, Forecast ($m), 2010-2018 24Figure 16: UTI Therapeutics Market, Germany , Revenue ($m), 2005-2010 25Figure 17: UTI Therapeutics Market, Germany, Forecast ($m), 2010-2018 26Figure 18: UTI Therapeutics Market, Italy, Revenue ($m), 2005-2010 27Figure 19: UTI Therapeutics Market, Italy, Forecast ($m), 2010-2018 28Figure 20: UTI Therapeutics Market, Spain, Revenue ($m), 2005-2010 29Figure 21: UTI Therapeutics Market, Spain, Forecast ($m), 2010-2018 30Figure 22: UTI Therapeutics Market, The UK, Revenue ($m), 2005-2010 31Figure 23: UTI Therapeutics Market, The UK, Forecast ($m), 2010-2018 32Figure 24: UTI Therapeutics Market, Japan, Revenue ($m), 2005-2010 33Figure 25: UTI Therapeutics Market, Japan, Forecast ($m), 2010-2018 34Figure 26: UTI Therapeutics Market , Key Events Impacting the Future Market 36Figure 27: Opportunity and Unmet Need in the UTI Therapeutics Market, 2011 37Figure 28: UTI Therapeutics - Strategic Competitor Assessment, 2011 39Figure 29: UTI Therapeutics - Pipeline by Phase of Clinical Development, 2011 45Figure 30: UTI Therapeutics Market - Clinical Pipeline by Mechanism of Action, 2011 47Figure 31: Technology Trends Analytical Framework of the UTI Pipeline, 2011 48Figure 32: Technology Trends Analytical Framework of The UTI Therapeutics Pipeline - Description, 2011 49Figure 33: UTI Therapeutics - Clinical Trials by Country, 2011 52Figure 34: UTI Therapeutics - Clinical Trials by Phase, 2011 53Figure 35: UTI Therapeutics - Clinical Trials by Status, 2011 54Figure 36: UTI Therapeutics - Overall Sponsors, 2011 55Figure 37: UTI Therapeutics - Prominent Sponsors, 2011 56Figure 38: UTI Therapeutic Clinical Trial - Company Sponsors by Phase, 2011 57Figure 39: Implications for Future Market Competition in the UTI Therapeutics Market, 2011 58Figure 40: UTI Therapeutics Market - Clinical Pipeline by Company, 2011 59Figure 41: GlobalData Market Forecasting Model 70
Email: [email protected]
Intl: +1 805-652-2626
All major researchers estimate there will be tens of billions devices – computers, smartphones, tablets, and sensors – connected to the Internet by 2020. This number will continue to grow at a rapid pace for the next several decades. With major technology companies and startups seriously embracing IoT strategies, now is the perfect time to attend @ThingsExpo in Silicon Valley. Learn what is going on, contribute to the discussions, and ensure that your enterprise is as "IoT-Ready" as it can be!
Oct. 1, 2014 04:15 PM EDT Reads: 2,320
Noted IoT expert and researcher Joseph di Paolantonio (pictured below) has joined the @ThingsExpo faculty. Joseph, who describes himself as an “Independent Thinker” from DataArchon, will speak on the topic of “Smart Grids & Managing Big Utilities.” Over his career, Joseph di Paolantonio has worked in the energy, renewables, aerospace, telecommunications, and information technology industries. His expertise is in data analysis, system engineering, Bayesian statistics, data warehouses, business intelligence, data mining, predictive methods, and very large databases (VLDB). Prior to DataArchon, he served as a VP and Principal Analyst with Constellation Group. He is a member of the Boulder (Colo.) Brain Trust, an organization with a mission “to benefit the Business Intelligence and data management industry by providing pro bono exchange of information between vendors and independent analysts on new trends and technologies and to provide vendors with constructive feedback on their of...
Oct. 1, 2014 03:30 PM EDT Reads: 803
Software AG helps organizations transform into Digital Enterprises, so they can differentiate from competitors and better engage customers, partners and employees. Using the Software AG Suite, companies can close the gap between business and IT to create digital systems of differentiation that drive front-line agility. We offer four on-ramps to the Digital Enterprise: alignment through collaborative process analysis; transformation through portfolio management; agility through process automation and integration; and visibility through intelligent business operations and big data.
Sep. 30, 2014 10:30 AM EDT Reads: 1,547
There will be 50 billion Internet connected devices by 2020. Today, every manufacturer has a propriety protocol and an app. How do we securely integrate these "things" into our lives and businesses in a way that we can easily control and manage? Even better, how do we integrate these "things" so that they control and manage each other so our lives become more convenient or our businesses become more profitable and/or safe? We have heard that the best interface is no interface. In his session at Internet of @ThingsExpo, Chris Matthieu, Co-Founder & CTO at Octoblu, Inc., will discuss how these devices generate enough data to learn our behaviors and simplify/improve our lives. What if we could connect everything to everything? I'm not only talking about connecting things to things but also systems, cloud services, and people. Add in a little machine learning and artificial intelligence and now we have something interesting...
Sep. 29, 2014 06:45 AM EDT Reads: 1,900
Last week, while in San Francisco, I used the Uber app and service four times. All four experiences were great, although one of the drivers stopped for 30 seconds and then left as I was walking up to the car. He must have realized I was a blogger. None the less, the next car was just a minute away and I suffered no pain. In this article, my colleague, Ved Sen, Global Head, Advisory Services Social, Mobile and Sensors at Cognizant shares his experiences and insights.
Sep. 28, 2014 09:45 AM EDT Reads: 1,553
We are reaching the end of the beginning with WebRTC and real systems using this technology have begun to appear. One challenge that faces every WebRTC deployment (in some form or another) is identity management. For example, if you have an existing service – possibly built on a variety of different PaaS/SaaS offerings – and you want to add real-time communications you are faced with a challenge relating to user management, authentication, authorization, and validation. Service providers will want to use their existing identities, but these will have credentials already that are (hopefully) irreversibly encoded. In his session at Internet of @ThingsExpo, Peter Dunkley, Technical Director at Acision, will look at how this identity problem can be solved and discuss ways to use existing web identities for real-time communication.
Sep. 27, 2014 11:30 PM EDT Reads: 1,926
Can call centers hang up the phones for good? Intuitive Solutions did. WebRTC enabled this contact center provider to eliminate antiquated telephony and desktop phone infrastructure with a pure web-based solution, allowing them to expand beyond brick-and-mortar confines to a home-based agent model. It also ensured scalability and better service for customers, including MUY! Companies, one of the country's largest franchise restaurant companies with 232 Pizza Hut locations. This is one example of WebRTC adoption today, but the potential is limitless when powered by IoT. Attendees will learn real-world benefits of WebRTC and explore future possibilities, as WebRTC and IoT intersect to improve customer service.
Sep. 27, 2014 10:30 PM EDT Reads: 1,842
From telemedicine to smart cars, digital homes and industrial monitoring, the explosive growth of IoT has created exciting new business opportunities for real time calls and messaging. In his session at Internet of @ThingsExpo, Ivelin Ivanov, CEO and Co-Founder of Telestax, will share some of the new revenue sources that IoT created for Restcomm – the open source telephony platform from Telestax. Ivelin Ivanov is a technology entrepreneur who founded Mobicents, an Open Source VoIP Platform, to help create, deploy, and manage applications integrating voice, video and data. He is the co-founder of TeleStax, an Open Source Cloud Communications company that helps the shift from legacy IN/SS7 telco networks to IP-based cloud comms. An early investor in multiple start-ups, he still finds time to code for his companies and contribute to open source projects.
Sep. 27, 2014 10:30 PM EDT Reads: 2,300
The Internet of Things (IoT) promises to create new business models as significant as those that were inspired by the Internet and the smartphone 20 and 10 years ago. What business, social and practical implications will this phenomenon bring? That's the subject of "Monetizing the Internet of Things: Perspectives from the Front Lines," an e-book released today and available free of charge from Aria Systems, the leading innovator in recurring revenue management.
Sep. 27, 2014 09:45 PM EDT Reads: 2,522
The Internet of Things will put IT to its ultimate test by creating infinite new opportunities to digitize products and services, generate and analyze new data to improve customer satisfaction, and discover new ways to gain a competitive advantage across nearly every industry. In order to help corporate business units to capitalize on the rapidly evolving IoT opportunities, IT must stand up to a new set of challenges.
Sep. 27, 2014 08:45 PM EDT Reads: 2,396
There’s Big Data, then there’s really Big Data from the Internet of Things. IoT is evolving to include many data possibilities like new types of event, log and network data. The volumes are enormous, generating tens of billions of logs per day, which raise data challenges. Early IoT deployments are relying heavily on both the cloud and managed service providers to navigate these challenges. In her session at 6th Big Data Expo®, Hannah Smalltree, Director at Treasure Data, to discuss how IoT, Big Data and deployments are processing massive data volumes from wearables, utilities and other machines.
Sep. 27, 2014 01:00 PM EDT Reads: 2,062
P2P RTC will impact the landscape of communications, shifting from traditional telephony style communications models to OTT (Over-The-Top) cloud assisted & PaaS (Platform as a Service) communication services. The P2P shift will impact many areas of our lives, from mobile communication, human interactive web services, RTC and telephony infrastructure, user federation, security and privacy implications, business costs, and scalability. In his session at Internet of @ThingsExpo, Erik Lagerway, Co-founder of Hookflash, will walk through the shifting landscape of traditional telephone and voice services to the modern P2P RTC era of OTT cloud assisted services.
Sep. 26, 2014 11:45 PM EDT Reads: 1,578
While great strides have been made relative to the video aspects of remote collaboration, audio technology has basically stagnated. Typically all audio is mixed to a single monaural stream and emanates from a single point, such as a speakerphone or a speaker associated with a video monitor. This leads to confusion and lack of understanding among participants especially regarding who is actually speaking. Spatial teleconferencing introduces the concept of acoustic spatial separation between conference participants in three dimensional space. This has been shown to significantly improve comprehension and conference efficiency.
Sep. 26, 2014 10:45 PM EDT Reads: 1,512
The Internet of Things is tied together with a thin strand that is known as time. Coincidentally, at the core of nearly all data analytics is a timestamp. When working with time series data there are a few core principles that everyone should consider, especially across datasets where time is the common boundary. In his session at Internet of @ThingsExpo, Jim Scott, Director of Enterprise Strategy & Architecture at MapR Technologies, will discuss single-value, geo-spatial, and log time series data. By focusing on enterprise applications and the data center, he will use OpenTSDB as an example to explain some of these concepts including when to use different storage models.
Sep. 26, 2014 07:45 PM EDT Reads: 2,322
SYS-CON Events announced today that Gridstore™, the leader in software-defined storage (SDS) purpose-built for Windows Servers and Hyper-V, will exhibit at SYS-CON's 15th International Cloud Expo®, which will take place on November 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA. Gridstore™ is the leader in software-defined storage purpose built for virtualization that is designed to accelerate applications in virtualized environments. Using its patented Server-Side Virtual Controller™ Technology (SVCT) to eliminate the I/O blender effect and accelerate applications Gridstore delivers vmOptimized™ Storage that self-optimizes to each application or VM across both virtual and physical environments. Leveraging a grid architecture, Gridstore delivers the first end-to-end storage QoS to ensure the most important App or VM performance is never compromised. The storage grid, that uses Gridstore’s performance optimized nodes or capacity optimized nodes, starts with as few a...
Sep. 26, 2014 06:15 PM EDT Reads: 1,692
The Transparent Cloud-computing Consortium (abbreviation: T-Cloud Consortium) will conduct research activities into changes in the computing model as a result of collaboration between "device" and "cloud" and the creation of new value and markets through organic data processing High speed and high quality networks, and dramatic improvements in computer processing capabilities, have greatly changed the nature of applications and made the storing and processing of data on the network commonplace. These technological reforms have not only changed computers and smartphones, but are also changing the data processing model for all information devices. In particular, in the area known as M2M (Machine-To-Machine), there are great expectations that information with a new type of value can be produced using a variety of devices and sensors saving/sharing data via the network and through large-scale cloud-type data processing. This consortium believes that attaching a huge number of devic...
Sep. 26, 2014 06:00 PM EDT Reads: 1,617
Innodisk is a service-driven provider of industrial embedded flash and DRAM storage products and technologies, with a focus on the enterprise, industrial, aerospace, and defense industries. Innodisk is dedicated to serving their customers and business partners. Quality is vitally important when it comes to industrial embedded flash and DRAM storage products. That’s why Innodisk manufactures all of their products in their own purpose-built memory production facility. In fact, they designed and built their production center to maximize manufacturing efficiency and guarantee the highest quality of our products.
Sep. 26, 2014 05:00 PM EDT Reads: 1,614
Can call centers hang up the phones for good? Intuitive Solutions did. WebRTC enabled this contact center provider to eliminate antiquated telephony and desktop phone infrastructure with a pure web-based solution, allowing them to expand beyond brick-and-mortar confines to a home-based agent model. Download Slide Deck: ▸ Here
Sep. 26, 2014 10:00 AM EDT Reads: 1,553
All major researchers estimate there will be tens of billions devices - computers, smartphones, tablets, and sensors - connected to the Internet by 2020. This number will continue to grow at a rapid pace for the next several decades. Over the summer Gartner released its much anticipated annual Hype Cycle report and the big news is that Internet of Things has now replaced Big Data as the most hyped technology. Indeed, we're hearing more and more about this fascinating new technological paradigm. Every other IT news item seems to be about IoT and its implications on the future of digital business.
Sep. 26, 2014 10:00 AM EDT Reads: 2,100
BSQUARE is a global leader of embedded software solutions. We enable smart connected systems at the device level and beyond that millions use every day and provide actionable data solutions for the growing Internet of Things (IoT) market. We empower our world-class customers with our products, services and solutions to achieve innovation and success. For more information, visit www.bsquare.com.
Sep. 26, 2014 09:45 AM EDT Reads: 1,463